et al.. Indoor residential exposure to semivolatile organic compounds in France. Environment International, Elsevier, 2017, 109, pp.Aggregate exposure; cumulative exposure; chemicals; Monte Carlo simulation; indoor air 21 quality; dermal exposure. 22 ABSTRACT 23 Multiple chemicals are emitted in residential accommodation. Aggregate Daily Doses (ADD) 24 (ng/kg-bw/d) were estimated for 32 semivolatile organic compounds (SVOCs) of different 25 chemical families that are frequently detected in French dwellings in both air and settled dust.
INTRODUCTION

Ingestion of settled dust
Where C dust is the SVOC concentration in settled dust (ng/g), DI is the amount of dust 99 ingested by an individual per day (g/d), f oral is the oral bioavailability of the SVOC (-), f dust is 100 the bioaccessibility of the SVOC from the dust (-), t is the fraction of time spent in dwellings 101 (-), BW is the body weight (kg), and DD ing-dust is expressed in ng/kg-bw/d.
102
Inhalation of indoor air
Where C part is the SVOC particulate phase concentration (ng/ m 3 ), C gas is the SVOC gas phase 105 concentration (ng/m 3 ), IR is the inhalation rate for an individual per day (m 3 /d), f pulm is the pulmonary bioavailability of the SVOC (-), t is the fraction of time spent in dwellings (-), BW 107 is the body weight (kg), and DD inh-air is expressed in ng/kg-bw/d. 108 Dermal contact with the gas phase
Where C gas is the SVOC gas phase concentration (ng/m 3 ), k p-g is the SVOC transdermal 111 permeability coefficient (m/h), BSA is the body surface area (m²), t is the daily duration 112 exposure (h/d), BW is the body weight (kg), and DD derm-gas is expressed in ng/kg-bw/d. The 113 steady-state model adapted by Weschler and Nazaroff (2012, 2014) used to estimate k p-g is 114 described in more detail in Supplemental Material (see S1). This requires use of the SVOC 115 octanol/water partition coefficients (log (K ow )), Henry's law constants (H) and coefficients 116 describing the external transport of a gaseous SVOC from the bulk indoor air to the boundary 117 layer adjacent to the skin (ɣ d ).
118
The ADD for a single SVOC for an individual was then calculated by summing the previous 119 doses according to the following equation, and expressed in ng/kg-bw/d:
Parameter estimation for exposure model: Parameter distributions were constructed or 122 retrieved from the literature as detailed below. Some of these parameters will be the same for 123 all SVOCs (ɣ d , BW, BSA, IR, DI and t) while others will vary from one compound to another 124 (f oral , f dust , f pulm , log (K ow ), H, C dust , C part and C gas ).
125
Physical and chemical parameters period of one week, and assumed to be representative of each dwelling as a whole. SVOC gas 152 phase concentrations were not available at national scale; data from 30 French dwellings measurements, lognormal distributions were fitted using summary statistics when > 75% of 157 data were above LOD (Burmaster 1997) . This concerns 20 and 14 compounds, for settled dust 158 and PM measurements respectively. Where detection frequency ranged from 20 to 75%, the 159 maximum-likelihood estimation (MLE) was used to estimate lognormal distributions (Helsel 160 2011; Helsel and Hirsch 1992) . This statistical method could be used to estimate the 161 undetected data in the studies of Mandin et al. (2014 Mandin et al. ( , 2016 , because sample sizes were large 162 enough -with 145 and 285 samples for dust and PM respectively. The number of compounds 163 concerned was 7 for settled dust and 11 for PM measurements. Where detection frequency 164 ranged from 1 to 20%, custom distribution was modeled with discrete probability for the 165 quantified values, and continuous uniform probability from 0 to LOD and from LOD to LOQ.
166
The number of compounds concerned was 5 for settled dust and 7 for PM measurements. For Table S3 for corresponding distribution and input parameters. other compound from the same chemical family was assessed. See Table S4 for 205 corresponding distributions and input parameters for each SVOC. Lognormal distributions were used for BW, BSA and DI. Normal distributions were used for 214 IR and t. See Table S5 for corresponding distributions and input parameters.
215
Simulation: DD from all three routes of exposure (Eq. 1 to 3) and ADD (Eq. 4) were 216 estimated using Crystal Ball® software (Oracle © , version 11.1.1.3.00). Latin Hypercube two-217 dimensional simulations were carried out with 500,000 runs for each SVOC, and each age 218 group. Two-dimensional simulations take into account both the uncertainty (lack of 219 knowledge about a parameter) and the variability (heterogeneity of a parameter in a 220 population) of the input parameters. The following parameters were considered variable (i.e. Table S6 ) ranged from 1.2 for 2,2',4,4',5-pentabromodiphenylether 239 (BDE 99) to 12 for 2,3,3',4,4'-pentachlorobiphenyl (PCB 105), with a median value of 4. The 240 median uncertainty on the mean was 40%, ranging from 11% for the benzo[a]pyrene to 230% 241 for 2,3',4,4',5-pentachlorobiphenyl (PCB 118) (see detailed relative errors in Table S13 ).
242
The relative contribution of exposure pathways to aggregated median exposure is presented in octanol-air partition coefficient (log (K oa )) value of 9 or less (see Table S1 ) and expected to be primarily gaseous (Weschler and Nazaroff, 2012), inhalation and dermal contact with the gas 248 phase were the dominant routes of exposure: fluorene, anthracene, aldrin, dieldrin, tonalide, 249 galaxolide, tributylphosphate, diethyl phthalate (DEP), dibutyl phthalate (DBP), DiBP and 250 2,4,4'-trichlorobiphenyl (PCB 28), 2,4',5-trichlorobiphenyl (PCB 31) and 2,2',5,5'-251 tetrachlorobiphenyl (PCB 52). For less volatile SVOCs -that is those compounds having a log 252 (K oa ) value of 13 or greater (see Table S1 ) and expected to be primarily in the particle phase 253 (Weschler and Nazaroff, 2012), dust ingestion was the dominant route of exposure: 254 diethylhexyl phthalate (DEHP), di-isononyl phthalate (DiNP) and 2,2',4,4',5,6'-255 hexabromodiphenylether (BDE 154). The contribution made by different pathways was more 256 contrasted for SVOCs having a log (K oa ) value of between 9 and 13 (see Table S1 ). On the 257 whole, air was the dominant exposure medium (sum of inhalation and dermal contact > 50% 258 of ADD) for 28 compounds out of 32, while dust was the major contributor for DEHP, DiNP, 259 benzyl butyl phthalate (BBP) and 2,2',4,5,5'-pentachlorobiphenyl (PCB 101). Overall, dust 260 ingestion is more contributive to exposure for less volatile chemicals, although this is not the 261 case with BBP and PCB 101, both of which are found in relatively high concentrations in 262 dust.
263
Relative contributions of exposure pathways for P95 values were similar to median values. 264 Notable exceptions were that higher contributions from dust ingestion were found for PCB 265 118, 2,2',3,4,4',5'-hexachlorobiphenyl (PCB 138) and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 266 153), and higher contributions from inhalation were found for benzo[a]pyrene and DBP.
267
[ Figure 2 ] 268 The main sensitivity analysis results are shown in Figure 2 (see Table S7 for detailed results).
269
These reveal that contamination parameters are most influential: C gas , C part and C dust , the only to least volatile (DiNP). Among the most volatile SVOCs, C gas tended to be the more 278 influential parameter, while C dust and C part appeared influential for the least volatile. Lastly, 279 we note that within each age group, human parameters were not influential.
280
[ Figure 3 ] 281 ADD (ng/kg-bw/d) estimates for the 32 SVOCs for four age groups are shown in Figure 3 : 282 infants aged 0 to 1 months, infants aged 1 to 3 months, children aged 2 to 3 years and adults 283 aged 21 to 30 years. As expected, ADD decreases with age because of increasing BW -except 284 within the [0-1 month] category where the dust ingestion rate equals 0 mg, and ADD may be 285 lower in comparison with other groups. This is true in particular of compounds making a 286 major contribution to dust ingestion (PCB 101, BBP, DEHP and DiNP). Detailed results for 287 ADD across all 11 age groups (birth to age 30) are shown in Tables S8 to S18.
288
DISCUSSION
289
Indoor exposure to 32 SVOCs was modeled using contamination measurements from 290 dwellings and human body parameters. ADD spanned orders of magnitude from 8.7 pg/kg- chemical families via gas-and particle-phase inhalation, dermal contact with gas phase, and 297 ingestion of settled dust; 2) use of field measurements in dust, particulate and gaseous phases; 298 3) use, when available, of large and nationwide representative datasets; 4) choice of a two-299 dimensional probabilistic approach, and 5) consideration of many age groups.
300
Study limitations include: 1) use of an exposure model that neglects dynamic conditions; 2) 301 use of different data sets for different exposure media, and 3) uncertainty analysis being 302 restricted to parameter uncertainty. 303 We used steady-state models to estimate indoor exposure to SVOCs. Because indoor air 304 measurements were performed over a period of one week, and settled dust being collected in a 305 vacuum cleaner, we assumed that equilibrium had been reached. Because we frequently move 306 from one environment into another, or between rooms having different concentrations, where a lower LOD or LOQ was used by the authors (see Table S2 ). This concerned settled 317 dust and gas phase concentrations for the 2,4,4'-tribromodiphenylether (BDE 28), and gas 318 phase concentration alone for 12 other SVOCs: benzo[a]pyrene, PCB 31, PCB 105, PCB 118, calculation of DD derm-gas and then ADD. Up to 34% of ADD variation for aldrin could be 395 explained by uncertainty in f pulm (see Table S7 ) because data for most of the SVOCs were 396 unavailable. Indeed, data were available for just two compounds: 2,2',4,4'-397 tetrabromodiphenylether (BDE 47) and benzo[a]pyrene, leading to modeling of uniform 398 distribution between 0 and 100% for most compounds (see Table S4 ) and to potential 399 overestimation of inhalation exposure. The same limit was encountered for the other uptake and variability for this parameter in our study. Nevertheless, we found that human body 414 parameters made a marginal or null contribution (see Table S7 ) to the variance of ADD for a 415 child aged 2 to 3 years, for each SVOC. It is however important to bear in mind both that we 416 ran the model age-group by age-group, and that these parameters can have a broader impact 417 when applied to a more diverse population. 
